A meta-analysis of Indonesian data shows that doubling the primaquine dose from 3.5 mg/kg to 7 mg/kg halves P. vivax recurrence rates at 6 months, but increases gastrointestinal and haemolytic side effects. Rapid G6PD screening becomes mandatory before deploying higher-dose regimens safely. — Photo by www.kaboompics.com on Pexels (Pexels License)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
